EarlySight

Einzelheiten

Land

Weltweit

Typologie

Eigenkapital

Endtermin

31/03/2025 (221 Tage)

Investoren

161

“EarlySight is devoted to enhancing the abilities of eye doctors to uncover the impacts of diseases that are often missed with standard care methods. Through pioneering technology, they aim to transform the early detection and monitoring of eye conditions, enabling more timely and effective interventions. This initiative seeks support to further their mission of empowering healthcare professionals and help them prevent vision loss.”